in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Amerigen Pharmaceuticals, Ningbo Menovo sign generics deal; Menovo to manufacture APIs
3:04 AM MDT | August 28, 2014 | Deepti Ramesh
Amerigen Pharmaceuticals (Lyndhurst, NJ) and Ningbo Menovo Pharmaceutical (Ningbo, China) have entered into a collaboration agreement for the development of generic pharmaceuticals, primarily targeting the US market. Amerigen and Menovo, under the terms of the agreement, will jointly develop products for Amerigen to commercialize in the United States. Menovo will be responsible for manufacturing the active pharmaceutical ingredient (API) and finished product whereas Amerigen will be responsible for clinical, regulatory and commercial activities in the United...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee